Structure Therapeutics (GPCR) Income Statement: Revenue & Earnings

Structure Therapeutics Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Structure Therapeutics Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	108.81	70.10	36.19	29.11	12.36
Selling, General & Administrative	49.41	32.67	16.37	8.59	3.54
Operating Expenses	158.23	102.78	52.56	37.70	15.91
Operating Income	-158.23	-102.78	-52.56	-37.70	-15.91
Other Income/Expense
Interest Income	36.03	13.39	1.26	0.00	0.17
Interest Expense	0.00	0.00	0.00	-0.12	0.00
Other Income/Expense	36.01	0.00	0.00	0.00	0.00
Income
Income Before Tax	-122.22	-89.38	-51.30	-37.82	-15.74
Income Tax Expense	0.31	0.24	0.02	0.23	0.14
Net Income	-122.53	-89.62	-51.32	-40.01	-15.88
Net Income - Continuous Operations	-122.53	-89.62	-51.32	-38.05	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-157.24	-102.48	-52.28	-37.62	0.00
EBIT	-158.23	-102.78	-52.56	-37.70	-15.91
Depreciation & Amortization	0.99	0.30	0.28	0.07	0.00
Earnings Per Share
Basic EPS	-2.00	-2.00	-17.00	-2.00	-8.00
Diluted EPS	-2.00	-2.00	-17.00	-2.00	-8.00
Basic Shares Outstanding	52.64	110.20	3.19	25.48	2.09
Diluted Shares Outstanding	52.64	110.20	3.19	25.48	2.09